Evidence map›Paper›PMID 26803169›Full record

Trial reportClinical nutrition (Edinburgh, Scotland)2017

Selenium supplementation has beneficial and detrimental effects on immunity to influenza vaccine in older adults.

Kamal Ivory, Elena Prieto, Caroline Spinks, Charlotte N Armah, Andrew J Goldson, Jack R Dainty, Claudio Nicoletti

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Clinical nutrition (Edinburgh, Scotland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 3 pooled it
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 3 syntheses or guidelines pooled it, 136 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. How does geographical diversity shape vaccine efficacy?Clinical and experimental vaccine research · 2024
    Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Nano selenium-enriched probioticFrontiers in immunology · 2023
    Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Kamal IvoryGut Health and Food Safety Programme, Institute of Food Research, Norwich, UK. Electronic address: kamal.ivory@ifr.ac.uk.
Elena PrietoGut Health and Food Safety Programme, Institute of Food Research, Norwich, UK. Electronic address: elenaprieto0102@gmail.com.
Caroline SpinksFood and Health Program, Institute of Food Research, Norwich, UK. Electronic address: caroline.spinks@ifr.ac.uk.
Charlotte N ArmahFood and Health Program, Institute of Food Research, Norwich, UK. Electronic address: charlotte.armah@ifr.ac.uk.
Andrew J GoldsonGut Health and Food Safety Programme, Institute of Food Research, Norwich, UK. Electronic address: Andrew.Goldson@ifr.ac.uk.
Jack R DaintyAnalytical Science Unit, Institute of Food Research, Norwich, UK.
Claudio NicolettiGut Health and Food Safety Programme, Institute of Food Research, Norwich, UK. Electronic address: claudio.nicoletti@ifr.ac.uk.
Norwich Research Park · GBQuadram Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BB/J00452945/1
6 · The paper itself

Abstract

BACKGROUND &

aimsMortality resulting from influenza (flu) virus infections occurs primarily in the elderly through declining immunity. Studies in mice have suggested beneficial effects of selenium (Se) supplementation on immunity to flu but similar evidence is lacking in humans. A dietary intervention study was therefore designed to test the effects of Se-supplementation on a variety of parameters of anti-flu immunity in healthy subjects aged 50-64 years.

methodsA 12-week randomized, double-blinded, placebo-controlled clinical trial (ClinicalTrials.govNCT00279812) was undertaken in six groups of individuals with plasma Se levels <110 ng/mL. Four groups were given daily capsules of yeast enriched with 0 μg Se/day (SeY-0/d; n = 20), 50 μg Se/d (SeY-50/d; n = 18), 100 μg Se/d (SeY-100/d; n = 21) or 200 μg Se/d (SeY-200/d; n = 23). Two groups were given onion-containing meals with either <1 μg Se/d (SeO-0/d; n = 17) or 50 μg Se/d (SeO-50/d; n = 18). Flu vaccine was administrated at week 10 and immune parameters were assessed until week 12.

resultsPrimary study endpoints were changes in cellular and humoral immune responses. Supplementation with SeY and SeO affected different aspects of cellular immunity. SeY increased Tctx-ADCC cell counts in blood (214%, SeY-100/d) before flu vaccination and a dose-dependent increase in T cell proliferation (500%, SeY-50/100/200/d), IL-8 (169%, SeY-100/d) and IL-10 (317%, SeY-200/d) secretion after in vivo flu challenge. Positive effects were contrasted by lower granzyme B content of CD8 cells (55%, SeY-200/d). SeO (Se 50 μg/d) also enhanced T cell proliferation after vaccination (650%), IFN-γ (289%), and IL-8 secretion (139%), granzyme (209%) and perforin (190%) content of CD8 cells but inhibited TNF-α synthesis (42%). Onion on its own reduced the number of NKT cells in blood (38%). These effects were determined by comparison to group-specific baseline yeast or onion control groups. Mucosal flu-specific antibody responses were unaffected by Se-supplementation.

conclusionSe-supplementation in healthy human adults with marginal Se status resulted in both beneficial and detrimental effects on cellular immunity to flu that was affected by the form of Se, supplemental dose and delivery matrix. These observations call for a thorough evaluation of the risks and benefits associated with Se-supplementation.

Indexed as

Dietary SupplementsImmunity, CellularAntibodies, ViralBody Mass IndexCell ProliferationCytokinesDietDose-Response Relationship, DrugDouble-Blind MethodFemaleHumansImmunoglobulin AImmunoglobulinsInfluenza, HumanInfluenza VaccinesMaleAntibodies, ViralCytokinesImmunoglobulin AImmunoglobulinsInfluenza VaccinesSeleniumCellular immunityFood supplementsHumoral immunityInfluenzaSelenium

Identifiers

PMID26803169
PMCPMC5381341
OpenAlexW2221588476

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.